Originally, Tesamorelin was FDA-approved for HIV-related fat redistribution
Supplemental strategies for enhanced protocols Researchers running retatrutide protocols often combine the compound with supportive interventions that enhance outcomes
It is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any medical condition or disease
Aronne, MD, FACP, FTOS, DABOM I am biased because I am one of the authors of this paper, but this must be mentioned because it is a new record: In the SURMOUNT-1 trial, after 3 years of treatment with tirzepatide, we were able to reduce the incidence of diabetes by 94% in people who started with prediabetes